Skip to main content
Full access
LETTER
Published Online: 1 October 2010

An Interesting Link Between Microgravity and Psychiatric Diseases

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: The exposure to altered microgravity during space travel has been shown to induce changes in the limbic system which are reflected in many of the physical behaviors seen in the astronauts. Although the neurobiological basis of this phenomenon is still obscure, several psychiatric issues including anxiety, depression, psychosis, psychosomatic symptoms, emotional problems, and cognitive changes have been observed after spaceflight. 1 However, studies evaluating the impact of a microgravity environment on brain function revealed significant CNS changes, and the direct effect of microgravity has already been shown by in vivo and in vitro animal studies. 2
It has recently been shown that microgravity caused an oxidative imbalance in the hypothalamus suggesting an organic interaction between the environment and the hypothalamic-pituitary-adrenal axis. 3 This was suggested by recent animal and human studies showing significant increases of prolactin, cortisol, and ACTH levels after exposure to the microgravity environment. This concurs with recent studies showing a strong and significant correlation between circulating stress hormones, psychological status, and transient metabolic changes on the special limbic and cortical regions in humans.
Another study evaluating the neurotransmitter receptor binding and NA+, K+-ATPase activity in the limbic and cortical regions after exposure to a microgravity environment showed significantly increased 5-HT 1 receptor number in the hippocampus in contrast to a significantly depressed cortical sodium-potassium pump activity. 4 This could be related to mechanisms of structural adaptation to a decreased afferent flow in the hemisphere cortex in microgravity. This was also suggested by studies indicating inhibited cortical function in simulated microgravity conditions. These findings are interesting in light of increasing evidence regarding the functional metabolic interaction between the cortex and the limbic system by the normal regulation of mood, the development of psychiatric diseases, and the recovery from depression after treatment. Additionally, the decreased afferent flow to the hemisphere cortex can arise as a result of sensory deprivation, which can be considered an unenriched environment.
We can hypothesize that cortisol-related decreases in cortical metabolism can be a risk factor for the development of psychiatric diseases, such as hippocampal damage, which has also been shown to predispose depression. An interesting animal study revealed that animals exposed to an unenriched environment are more likely to behave like depressive animals. This is supported by studies showing that an enriched environment is capable of reversing the stress-induced disturbances and enhancing the neurogenesis. 5
This finding suggests that weightlessness may affect adaptational processes not only due to weightlessness but also due to exposure to other stressors, which can mediate the psychobiological effects of the altered gravity experienced by microgravity conditions. However, the detailed underlying pathophysiological mechanism of such a possible link between stress, microgravity, and psychiatric diseases should be confirmed with further neuroimaging studies.

References

1.
Kanas N: Psychological, psychiatric, and interpersonal aspects of long-duration space missions. J Spacecr Rockets 1990; 27:457–463
2.
Adey WR: Effects of gravity on the functions of the central nervous system. Life Science Space Res 1964; 2:267–286
3.
Sarkar P, Sarkar S, Ramesh V, et al: Proteomic analysis of mouse hypothalamus under simulated microgravity. Neurochem Res 2008; 33:2335–2341
4.
Miller JD, McMillen BA, McConnaughey MM, et al: Effects of microgravity on brain neurotransmitter receptors. Eur J Pharmacol 1989; 161:165–171
5.
Burman OH, Parker RM, Paul ES, et al: Sensitivity to reward loss as an indicator of animal emotion and welfare. Biol Lett 2008; 4:330–333

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 451.e12
PubMed: 21037139

History

Published online: 1 October 2010
Published in print: Fall, 2010

Authors

Affiliations

Burak Yulug
University of Regensburg, Department of Neurology, Regensburg, Germany
Gokhan Erkol
University of Istanbul, Cerrahpasa Medical School, Department of Neurology, Istanbul, Turkey
Ertugrul Kilic
Brain Research Laboratory, University of Yeditepe, Istanbul

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share